VMVAX | VVORX | VMVAX / VVORX | |
Total Expense Ratio | 0.07 | 1.32 | 5% |
Annual Report Gross Expense Ratio | 0.07 | 1.32 | 5% |
Fund Existence | 14 years | 13 years | - |
Gain YTD | 5.532 | 4.667 | 119% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 30.6B | 5.21B | 588% |
Annual Yield % from dividends | 2.26 | 0.20 | 1,158% |
Returns for 1 year | 9.76 | 11.51 | 85% |
Returns for 3 years | 28.18 | 43.16 | 65% |
Returns for 5 years | 71.82 | 116.49 | 62% |
Returns for 10 years | 93.07 | 56.41 | 165% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NEXIX | 35.07 | 0.21 | +0.60% |
Shelton Sustainable Equity Institutional | |||
GEIYX | 17.89 | 0.09 | +0.51% |
GuideStone Funds Growth Equity Idx Instl | |||
TWUIX | 104.06 | 0.45 | +0.43% |
American Century Ultra® I | |||
MCRFX | 14.91 | 0.03 | +0.20% |
BlackRock Mid-Cap Value Investor C | |||
JHTGX | 19.96 | 0.02 | +0.10% |
JPMorgan Hedged Equity 3 R5 |